Inventory increased 24.3%
Inventory changed +24.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +24.3% from the comparable as-filed period.
Working capital changed -51.5% from the comparable as-filed period.
Inventory / revenue changed +684 basis points from the comparable as-filed period.
Cash / debt changed -1255 basis points from the comparable as-filed period.
Capital expenditure changed +114.0% from the comparable as-filed period.
Net income changed +23.9% from the comparable as-filed period.
Research & development changed +28.6% from the comparable as-filed period.
Revenue changed +11.8% from the comparable as-filed period.
Gross debt changed +17.1% from the comparable as-filed period.
Reported total debt changed +17.1% from the comparable as-filed period.
Noncurrent long-term debt changed +20.7% from the comparable as-filed period.
Stock-based compensation changed +31.6% from the comparable as-filed period.
Gross margin changed +76 basis points from the comparable as-filed period.
Operating income changed +10.4% from the comparable as-filed period.
Free-cash-flow proxy changed +9.7% from the comparable as-filed period.
Gross profit changed +21.6% from the comparable as-filed period.
Operating margin changed -6 basis points from the comparable as-filed period.
Selling, general & administrative changed +24.1% from the comparable as-filed period.
Capex / revenue changed +100 basis points from the comparable as-filed period.
Shares outstanding changed -2.4% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
Cash & equivalents changed -10.7% from the comparable as-filed period.
Cost of revenue changed +10.9% from the comparable as-filed period.
Debt / revenue changed +176 basis points from the comparable as-filed period.
Debt / assets changed -133 basis points from the comparable as-filed period.
Operating cash-flow margin changed +93 basis points from the comparable as-filed period.
SBC / revenue changed +4 basis points from the comparable as-filed period.
Working capital / assets changed -23 basis points from the comparable as-filed period.
Current ratio changed -0.2% from the comparable as-filed period.
Operating cash flow / net income changed +6.4% from the comparable as-filed period.
Free-cash-flow margin changed -8 basis points from the comparable as-filed period.
R&D / revenue changed +1 basis points from the comparable as-filed period.
Current long-term debt changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.